HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DeGiorgio, C. M. Articles by Correale, J. Search for Related Content PubMed PubMed Citation Articles by DeGiorgio, C. M. Articles by Correale, J.

Serum neuron-specific enolase in the major subtypes of status epilepticus

From the Department of Neurology, University of Southern California (USC) School of Medicine, Los Angeles, CA.

Address correspondence and reprint requests to Dr. Christopher M. DeGiorgio, USC University Hospital, Neurophysiology, 2nd floor AMDG, 1500 San Pablo, Los Angeles, CA 90033.

OBJECTIVES: To determine the relative magnitudes of neuron-specific enolase (NSE) levels after complex partial status epilepticus (SE), absence SE, generalized convulsive SE, and subclinical generalized convulsive SE (frequently referred to as acute symptomatic myoclonic status epilepticus).

BACKGROUND: NSE is a marker of acute brain injury and blood–brain barrier dysfunction, which is elevated in SE.

METHODS: Serum NSE levels were drawn in 31 patients 1, 2, 3, and 7 days after SE. Patients were classified as acute symptomatic or remote symptomatic, and the duration and outcome of SE were determined and correlated with the peak NSE level.

RESULTS: NSE was elevated significantly in all four subtypes of SE, but NSE levels were highest in complex partial and subclinical SE. The mean peak NSE level for the complex partial SE group was 23.88 ng/mL (n = 12), 21.5 ng/mL for absence SE (n = 1), 14.10 ng/mL for the generalized convulsive SE group (n = 12), and 37.83 ng/mL for the subclinical SE group (n = 6), all of which was significantly higher than normal control subjects (5.02 ng/mL). Outcome was significantly different between the three groups (p = 0.0007), and was significantly worse for subclinical SE (p = 0.0005, subclinical versus generalized convulsive SE).

CONCLUSION: Serum NSE levels were highest in complex partial and subclinical generalized convulsive SE. The extremely high levels of NSE in subclinical SE reflect the severity of the acute neurologic insults and poor outcome common to subclinical SE. High NSE levels in complex partial SE reflects the long duration of SE in this subgroup, and potential for brain injury.

This article has been cited by other articles:

				R Nandhagopal Generalised convulsive status epilepticus: an overview Postgrad. Med. J., November 1, 2006; 82(973): 723 - 732. [Abstract] [Full Text] [PDF]

				M. Wong, K. Ess, and M. Landt Cerebrospinal Fluid Neuron-Specific Enolase Following Seizures in Children: Role of Etiology J Child Neurol, April 1, 2002; 17(4): 261 - 264. [Abstract] [PDF]

				W. G. Mitchell Status Epilepticus and Acute Serial Seizures in Children J Child Neurol, January 1, 2002; 17(1_suppl): S36 - S43. [Abstract] [PDF]